Digital Health And Reimbursement Issues Divide Glucose Monitoring Market
Executive Summary
Innovative technology from companies such as Google offers the promise of new digital health options in the glucose monitoring market, while drastic reimbursement cuts affecting existing meters and supplies in the US are taking a noticeable toll on the major players already operating in the field. These competing factors have created a dichotomy characterized by opportunity on one side and uncertainly on the other, and that is forcing some competitors to re-think their business strategies.
You may also be interested in...
Google Moves Further Into Medical Device Space
Google is making further inroads into the medical device space with deals designed to move the company’s two highly touted eyewear products into use by medical professionals. For Google’s smart contact lens, the company has partnered with Alcon to develop a glucose monitoring system, while Google Glass has become part of a project that will allow ambulance teams to transmit live views of patients in transit.
The Artificial Pancreas: A Race To The Finish
The first fully functional artificial pancreas for patients with diabetes could be ready for regulatory submission in the next few years. Medtronic has achieved notable success in this area to date, but positive clinical studies have put J&J in a good position as well, and the medical community is watching closely as the major developments in this groundbreaking endeavor continue to move forward.
The Artificial Pancreas: A Race To The Finish
The race to develop a fully functional artificial pancreas for patients with diabetes is entering the later stages, and the first such device could be ready for regulatory submission in the next few years. Medtronic has achieved notable success in this area to date, but positive clinical studies have put J&J in a good position as well, and the medical community is watching closely as the major developments in this groundbreaking endeavor continue to move forward.